1.
Freimann H, Calderoni A, Cornu P, Olie R. Daily practice use of bortezomib in relapsed/refractory multiple myeloma: Safety/efficacy results of a compassionate use program in Switzerland. Swiss Med Wkly [Internet]. 2007 Jun. 2 [cited 2024 May 15];137(2122):317-22. Available from: https://smw.ch/index.php/smw/article/view/736